Skip to content

Vasa Ghrita NetraTarpan and Mahatriphaladi Ghrita NetraTarpan in the Treatment of Myopia for the improvement in vision

Evaluation of Comparative Efficacy of Vasa Ghrita NetraTarpan versus Mahatriphaladi Ghrita NetraTarpan in the Management of Simple Myopia Timir Randomized controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090550
Enrollment
54
Registered
2025-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

None listed

Sponsors

Dr Nishant Vishnu Farkade
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients are willing to give informed consent Patient age between 16 and 25 years No History of major ocular or systemic disease The patient is showing signs and symptoms of simple myopia as per Ayurveda Modern spectacles -0.25 to -2.75 dioptres

Exclusion criteria

Exclusion criteria: Patient with history of eye trauma and surgeries Patient showing degenerative changes in posterior segment

Design outcomes

Primary

MeasureTime frame
Improvement in Visual acuity by Snellen chart Autorefractometer readings Timepoint: 1 month

Secondary

MeasureTime frame
Improvement in Keratometry K1 K2 Improvement in A scan Axial lengthTimepoint: 1 month

Countries

India

Contacts

Public ContactDr Roshna Rathi

Mahatma Gandhi Ayurveda College Hospital and Research Center Salod Wardha

roshna.bhutada@dmiher.edu.in8766866422

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026